Latest News about why it's moving
Recent news which mentions why it's moving
Atlassian Q1 Earnings: Revenue Beat, EPS Beat, Company Says 'We're Not Just Marketing AI, We're Shipping It'
October 31, 2024
From Benzinga
From Benzinga
What's Going On With Spirit Airlines (SAVE) Stock?
October 31, 2024
From Benzinga
What's Going On With Chevron (CVX) Stock Ahead Of Q3 Earnings?
October 31, 2024
From Benzinga
Why Camping World Holdings (CWH) Stock Is Down 11% Today
October 31, 2024
From Benzinga
Ford To Halt F-150 EV Production For 7 Weeks Next Month
October 31, 2024
From Benzinga
From Benzinga
What's Going On With Roku Stock Thursday?
October 31, 2024
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
From Benzinga
What's Going On With Cinemark Holdings Stock Thursday?
October 31, 2024
From Benzinga
Root Stock Is Soaring Thursday: What's Going On?
October 31, 2024
From Benzinga
STMicroelectronics' Q3 Results Highlight Weak Automotive Demand, Gross Margin Squeeze: Details
October 31, 2024
From Benzinga
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
October 31, 2024
From Benzinga
Ambev Q3 Sales Miss Expectations As Volume Growth Stalls; Shares Dip
October 31, 2024
From Benzinga
From Benzinga
Altria Q3: Earnings Beat, NJOY Gains Ground, But Marlboro Loses Share In Shrinking Market
October 31, 2024
From Benzinga
TotalEnergies Boasts Strong Revenue Despite Q3 EPS Miss, Decline In LNG And Production
October 31, 2024
From Benzinga
What's Going On With Enovix Stock Thursday?
October 31, 2024
From Benzinga
From Benzinga
Aptiv's Q3 Revenue Falls Short Of Estimates, Shares Slide
October 31, 2024
From Benzinga
Peloton Gears Up For Next Chapter: Sales Beat, Apple Alum As CEO, And Strong Margin Gains
October 31, 2024
From Benzinga
Eaton Q3 Earnings: Revenue Miss, EPS Beat, Raised Guidance On Continued 'Strong Demand'
October 31, 2024
From Benzinga
Cigna's Q3 Profit Beats Street On Strong Demand For Pharmacy Benefit Management's Specialty Drugs, New Clients
October 31, 2024
From Benzinga
Hyatt's Earnings Miss Clouds Q3, Eyes Strong 2024 With Bold Pipeline And Expanding Member Base
October 31, 2024
From Benzinga
Southern Company Q3: Revenue Misses, But EPS Beats Expectations with Strong Utility Gains
October 31, 2024
From Benzinga
Merck Beats Q3 Estimates, But Lowers Annual Forecast As Gardasil Vaccine Hit By Low China Demand
October 31, 2024
From Benzinga
From Benzinga
From Benzinga
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
October 31, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
